3-(2-Amino-4-methyl-1,3-thiazol-5-yl)-4-methyl-4,5-dihydro-1H-1,2,4-triazole-5-thione

Catalog No. :
ACCSJP269
CAS No. :
587007-13-4
Molecular Formula :
C7H9N5S2
Molecular Weight :
227.32

IUPAC Name:5-(2-imino-4-methyl-2,3-dihydrothiazol-5-yl)-4-methyl-2,4-dihydro-3H-1,2,4-triazole-3-thione

3-(2-Amino-4-methyl-1,3-thiazol-5-yl)-4-methyl-4,5-dihydro-1H-1,2,4-triazole-5-thione structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg95%$113.00Login to see priceInquiryInquiry
100mg95%$158.00Login to see priceInquiryInquiry
250mg95%$219.00Login to see priceInquiryInquiry
1g95%$534.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name3-(2-Amino-4-methyl-1,3-thiazol-5-yl)-4-methyl-4,5-dihydro-1H-1,2,4-triazole-5-thione
IUPAC Name5-(2-imino-4-methyl-2,3-dihydrothiazol-5-yl)-4-methyl-2,4-dihydro-3H-1,2,4-triazole-3-thione
MDL No.MFCD09702195
Molecular FormulaC7H9N5S2
Molecular Weight227.32
SMILESS=C1N(C)C(C2=C(C)N=C(N)S2)=NN1
InChI KeyCPTCQKPQQFKAHK-UHFFFAOYSA-N
SynonymAURORA 23304;OTAVA-BB BB7216470001;5-(2-Amino-4-methyl-1,3-thiazol-5-yl)-4-methyl-2,4-dihydro-3H-1,2,4-triazole-3-thione;3H-1,2,4-Triazole-3-thione, 5-(2-amino-4-methyl-5-thiazolyl)-2,4-dihydro-4-methyl-;5-(2-amino-4-methylthiazol-5-yl)-4-methyl-2,4-dihydro-3h-1,2,4-triazole-3-thione
CAS No.587007-13-4

Synthetic Route by SureRoute

1. ACCSJP269 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACCSJP269 route product structure diagram
    ACCSJP269587007-13-4
Inquiry

2. ACCSJP269 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACCSJP269 route product structure diagram
    ACCSJP269587007-13-4
Inquiry

Comments (0)